Efficacy of Glucosamine Plus Diacerein Versus Monotherapy of Glucosamine: a Double-blind, Parallel Randomized Clinical Trial

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2016 Oct 13

PMID 27729073

Citations 5

Authors

Jatupon Kongtharvonskul

Patarawan Woratanarat

Mark McEvoy

John Attia

Siwadol Wongsak

Viroj Kawinwonggowit

Ammarin Thakkinstian

Affiliations

Soon will be listed here.

Abstract

Background: Patented crystalline glucosamine sulfate (pCGS) and diacerein monotherapy have been recommended for treatment of mild to moderate osteoarthritis (OA), but evidence of efficacy for combined treatments is lacking. Therefore, the aim of this study was to compare clinical outcomes (i.e., pain and Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC] score) at 6 months as well as the safety profile of treatment with combined pCGS and diacerein versus pCGS alone.

Methods: A double-blind, parallel randomized controlled superiority trial was conducted between August 2013 and August 2014 at Ramathibodi Hospital, Bangkok, Thailand. A total of 148 patients (74 patients in each group) was randomly allocated to receive pCGS plus diacerein or pCGS plus placebo daily. Adult patients with OA were eligible if they had a Kellgren-Lawrence grade of 2-3. The primary outcomes were visual analogue scale score (VAS) for pain and WOMAC subscores measured at 24 weeks after receiving treatment, using the intention-to-treat principle (nonresponder imputation).

Results: Among the 148 patients in the study, mean age and body mass index were 60 years and 28.1 kg/m, respectively. Mean VAS and minimal joint space width at baseline were 5.1 and 2.5 mm, respectively. The mean VAS values measured at 24 weeks were 2.97 and 2.88 in the pCGS plus diacerein and pCGS plus placebo groups, respectively. The estimated mean difference was 0.09 (95 % CI -0.75 to 0.94), which was not statistically significant (P = 0.710). In addition, the mean WOMAC total, pain, function, and stiffness scores for both groups were not significantly different, with corresponding means of 48.59, 12.02, 32.74, and 3.85 for the pCGS plus diacerein group and 48.69, 11.76, 32.47, and 4.16 for the pCGS plus placebo group. The risk of diarrhea and dyspepsia was very similar between the two groups, with risk ratios of 1.03 (95 % CI 0.56-1.89) and 0.91 (95 % CI 0.43-1.92), respectively.

Conclusions: This study did not demonstrate that coadministration of diacerein with pCGS improves pain and WOMAC score compared with pCGS monotherapy in patients with mild to moderate OA of the knee.

Trial Registration: ClinicalTrials.gov identifier: NCT01906801 . Registered on 20 July 2013.

Citing Articles

Comparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis.

Sumsuzzman D, Khan Z, Jung J, Hong Y, Yang W, Park K J Clin Med. 2024; 13(23).

PMID: 39685902 PMC: 11641979. DOI: 10.3390/jcm13237444.

Durable Effect of Acupuncture for Chronic Neck Pain: A Systematic Review and Meta-Analysis.

Fang J, Shi H, Wang W, Chen H, Yang M, Gao S Curr Pain Headache Rep. 2024; 28(9):957-969.

PMID: 38856887 PMC: 11416387. DOI: 10.1007/s11916-024-01267-x.

Risk factors for pain and functional impairment in people with knee and hip osteoarthritis: a systematic review and meta-analysis.

Sandhar S, Smith T, Toor K, Howe F, Sofat N BMJ Open. 2020; 10(8):e038720.

PMID: 32771991 PMC: 7418691. DOI: 10.1136/bmjopen-2020-038720.

CTX-II and YKL-40 in early diagnosis and treatment evaluation of osteoarthritis.

Wang P, Song J, Qian D Exp Ther Med. 2019; 17(1):423-431.

PMID: 30651816 PMC: 6307395. DOI: 10.3892/etm.2018.6960.

Modeling the effect of blunt impact on mitochondrial function in cartilage: implications for development of osteoarthritis.

Kapitanov G, Ayati B, Martin J PeerJ. 2017; 5:e3468.

PMID: 28729949 PMC: 5516774. DOI: 10.7717/peerj.3468.

References

Hart D, Spector T, Brown P, Wilson P, Doyle D, Silman A . Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis. 1991; 50(7):467-70. PMC: 1004459. DOI: 10.1136/ard.50.7.467. View

Kellgren J, Lawrence J . Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16(4):494-502. PMC: 1006995. DOI: 10.1136/ard.16.4.494. View

Pelletier J, Yaron M, Haraoui B, Cohen P, Nahir M, Choquette D . Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum. 2000; 43(10):2339-48. DOI: 10.1002/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P. View

Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati L . Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002; 162(18):2113-23. DOI: 10.1001/archinte.162.18.2113. View

Reginster J, Deroisy R, Rovati L, Lee R, Lejeune E, Bruyere O . Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001; 357(9252):251-6. DOI: 10.1016/S0140-6736(00)03610-2. View

Louthrenoo W, Nilganuwong S, Aksaranugraha S, Asavatanabodee P, Saengnipanthkul S . The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study. Osteoarthritis Cartilage. 2007; 15(6):605-14. DOI: 10.1016/j.joca.2007.02.021. View

Kuptniratsaikul V, Tosayanonda O, Nilganuwong S, Thamalikitkul V . The epidemiology of osteoarthritis of the knee in elderly patients living an urban area of Bangkok. J Med Assoc Thai. 2002; 85(2):154-61. View

Juni P, Reichenbach S, Dieppe P . Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol. 2006; 20(4):721-40. DOI: 10.1016/j.berh.2006.05.002. View

Parsons C, Clynes M, Syddall H, Jagannath D, Litwic A, van der Pas S . How well do radiographic, clinical and self-reported diagnoses of knee osteoarthritis agree? Findings from the Hertfordshire cohort study. Springerplus. 2015; 4:177. PMC: 4408304. DOI: 10.1186/s40064-015-0949-z. View

10.

Felson D . The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum. 1990; 20(3 Suppl 1):42-50. DOI: 10.1016/0049-0172(90)90046-i. View

11.

McCarty M . Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Med Hypotheses. 1998; 50(6):507-10. DOI: 10.1016/s0306-9877(98)90272-9. View

12.

Henrotin Y, Mobasheri A, Marty M . Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?. Arthritis Res Ther. 2012; 14(1):201. PMC: 3392795. DOI: 10.1186/ar3657. View

13.

Martel-Pelletier J, Mineau F, Jolicoeur F, Cloutier J, Pelletier J . In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. J Rheumatol. 1998; 25(4):753-62. View

14.

Dawson J, Linsell L, Zondervan K, Rose P, Randall T, Carr A . Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology (Oxford). 2004; 43(4):497-504. DOI: 10.1093/rheumatology/keh086. View

15.

Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe P, Egger M . Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004; 364(9450):2021-9. DOI: 10.1016/S0140-6736(04)17514-4. View

16.

Pavelka K, Trc T, Karpas K, Vitek P, Sedlackova M, Vlasakova V . The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. Arthritis Rheum. 2007; 56(12):4055-64. DOI: 10.1002/art.23056. View

17.

. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section. Ann Rheum Dis. 1996; 55(8):552-7. PMC: 1010237. DOI: 10.1136/ard.55.8.552. View

18.

Kuptniratsaikul V, Rattanachaiyanont M . Validation of a modified Thai version of the Western Ontario and McMaster (WOMAC) osteoarthritis index for knee osteoarthritis. Clin Rheumatol. 2007; 26(10):1641-5. DOI: 10.1007/s10067-007-0560-y. View

19.

Wandel S, Juni P, Tendal B, Nuesch E, Villiger P, Welton N . Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010; 341:c4675. PMC: 2941572. DOI: 10.1136/bmj.c4675. View

20.

Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S . Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2014; 74(5):851-8. DOI: 10.1136/annrheumdis-2013-203954. View